Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2007 October; 8(4): 249.
Published online 2007 July 18. doi:  10.1208/pt0804111
PMCID: PMC2750697

Formulation and evaluation of ethosomes for transdermal delivery of lamivudine


The purpose of the present research was to investigate the mechanism for improved intercellular and intracellular drug delivery from ethosomes using visualization techniques and cell line study. Ethosomal formulations were prepared using lamivudine as model drug and characterized in vitro, ex vivo and in vivo. Transmission electron microscopy, scanning electron microscopy, and fluorescence microscopy were employed to determine the effect of ethosome on ultrastructure of skin. Cytotoxicity and cellular uptake of ethosome were determined using T-lymphoid cell line (MT-2). The optimized ethosomal formulation showed 25 times higher transdermal flux (68.4±3.5 µg/cm2/h) across the rat skin as compared with that of lamivudine solution (2.8±0.2 µg/cm2/h). Microscopic studies revealed that ethosomes influenced the ultrastructure of stratum corneum. Distinct regions with lamellar stacks derived from vesicles were observed in intercellular region of deeper skin layers. Results of cellular uptake study showed significantly higher intracellular uptake of ethosomes (85.7%±4.5%) as compared with drug solution (24.9%±1.9%). The results of the characterization studies indicate that lipid perturbation along with elasticity of ethosomes vesicles seems to be the main contributor for improved skin permeation.

Keywords: Ethosomes, skin, transmission electron microscopy, scanning electron microscopy, fluorescence microscopy, cell line study

Full Text

The Full Text of this article is available as a PDF (497K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Jarvis B, Faulds D. Lamivudine: a review of its therapeutic potential in chronic hepatitis B. Drugs. 1999;58:101–141. doi: 10.2165/00003495-199958010-00015. [PubMed] [Cross Ref]
2. Dutta T, Jain NK. Targeting potential and anti-HIV activity of lamivudine-loaded mannosylated poly(propyleneimine) dendrimer. Biochim Biophys Acta. 2007;1770:681–686. [PubMed]
3. Schreier H, Bouwstra J. Liposomes and niosomes as a drug carriers: dermal and transdermal drug delivery. J Control Release. 1994;30:1–15. doi: 10.1016/0168-3659(94)90039-6. [Cross Ref]
4. Cevc G, Blume G, Schatzlein A, Gebauer D, Paul A. The skin: a pathway for the systemic treatment with patches and lipid based agent carriers. Adv Drug Deliv Rev. 1996;18:349–378. doi: 10.1016/0169-409X(95)00091-K. [Cross Ref]
5. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65:403–418. doi: 10.1016/S0168-3659(99)00222-9. [PubMed] [Cross Ref]
6. Touitou E, inventor. Composition of applying active substance to or through the skin. US patent 5 540 934. July 30, 1996.
7. Touitou E, inventor. Composition of applying active substance to or through the skin. US patent 5 716 638. October 2, 1998.
8. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials. 2001;22:3053–3059. doi: 10.1016/S0142-9612(01)00052-7. [PubMed] [Cross Ref]
9. Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Ind J Pharma Sci. 2004;66:72–81.
10. Bangham AD, Standish MM, Watkins JC. The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J Mol Biol. 1965;13:253–259. doi: 10.1016/S0022-2836(65)80094-8. [PubMed] [Cross Ref]
11. Lopez-Pinto JM, Gonzalez-Rodriguez ML, Robasco AM. Effect of cholesterol and ethanol on dermal delivery of DPPC liposome. Int J Pharm. 2005;298:1–12. doi: 10.1016/j.ijpharm.2005.02.021. [PubMed] [Cross Ref]
12. Jain S, Jain P, Jain NK. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013–1026. doi: 10.1081/DDC-120025458. [PubMed] [Cross Ref]
13. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv. 2005;2:223–233. doi: 10.2174/1567201054368020. [PubMed] [Cross Ref]
14. Bedoya LM, Sanchez-Palomino S, Abad MJ, Bermejo P, Alcami J. Anti-HIV activity of medicinal plant extracts. J Ethnopharmacol. 2001;77:113–116. doi: 10.1016/S0378-8741(01)00265-3. [PubMed] [Cross Ref]
15. Dusserre N, Lessard C, Paquette N, et al. Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS. 1995;9:833–841. doi: 10.1097/00002030-199508000-00002. [PubMed] [Cross Ref]
16. Uslu B, Ozkan SA. Determination of lamivudine and zidovudine in binary mixtures using first derivative spectrophotometric, first derivative of the ratio-spectra and high performance liquid chromatography-UV methods. Anal Chim Acta. 2002;466:175–185. doi: 10.1016/S0003-2670(02)00545-7. [Cross Ref]
17. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106:99–110. doi: 10.1016/j.jconrel.2005.04.007. [PubMed] [Cross Ref]
18. Lasic D, Weiner N, Riaz M, Martin F. Liposomes. In: Lieberman A, Rieger M, Banker G, editors. Pharmaceutical Dosage Forms: Disperse Systems. vol. 3. New York, NY: Marcel Dekker; 1998. pp. 43–86.
19. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes Vs liposomes. Biomaterials. 2000;21:1879–1885. doi: 10.1016/S0142-9612(00)00063-6. [PubMed] [Cross Ref]
20. Van den Bergh BAI, Swartzendruber DC, Bos-Van der Geest A, et al. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J Microscopy. 1997;187:125–133. doi: 10.1046/j.1365-2818.1997.2200779.x. [PubMed] [Cross Ref]
21. Kim YH, Ghanem AH, Mahmoud H, Higuchi WI. Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: mechanism(s) of action. Int J Pharm. 1992;80:17–31. doi: 10.1016/0378-5173(92)90258-4. [Cross Ref]
22. Krishnaiah YSR, Bhaskar P, Satyanarayana V. Penetration-enhancing effect of ethanol water solvent system and ethanolic solution of carvone on transdermal permeability of nimodipine from HPMC gel across rat abdominal skin. Pharm Dev Technol. 2004;9:63–74. doi: 10.1081/PDT-120027419. [PubMed] [Cross Ref]
23. Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membrane from an ethosomal carrier. J Control Release. 2004;187:1–15. [PubMed]
24. Oussoren C, Magnani M, Fraternale A, et al. Liposomes as carrier of the antiviral agent dideoxycytidine-5′-triphosphate. Int J Pharm. 1999;180:261–270. doi: 10.1016/S0378-5173(99)00016-2. [PubMed] [Cross Ref]
25. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223–261. doi: 10.1146/ [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists